FSE administration inhibited the production inflammatory cytokines (IL-1β and TNF-α), reduced the levels of inflammation-related markers (myeloperoxidase and intercellular adhesion molecule 1), decreased the expression COX-2 and iNOS, and down-regulated the expression of NF-κB in EIU-rats.